Psoriatic Arthritis

Knowledge is power. Are you facing a new diagnosis or recurrence of Psoriatic Arthritis? The Spine Community Psoriatic Arthritis Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Psoriatic Arthritis. Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. Learn more about Psoriatic Arthritis.

The Spine Community Psoriatic Arthritis Community & Discussions

You are not alone—The Spine Community is the leading Social Media Application for individuals seeking information, inspiration, and support for back pain and conditions of the spine. The network offers patients and caregivers a thriving community for support and information. Login or register here.

PSORIATIC ARTHRITIS NEWS TIPS & FEATURES

Ask The Expert About Ankylosing Spondylitis Back Pain and other Inflammatory/Arthritic Conditions of The Spine

January 10, 2018

Ask The Expert About Ankylosing Spondylitis Back Pain and other Inflammatory/Arthritic Conditions of The Spine

By cancerconnect cancerconnect

TheSpineCommunity Presents: Ask the Expert Series with Dr. David Borenstein TheSpineCommunity Presents: Ask the Expert Series David G. Borenstein, MD will be answering questions in TheSpineCommunity on ankylosing spondylitis (AS) and back pain the week of January 15th.   TheSpineCommunity is an online resource center and support community for individuals affected with ankylosing spondylitis and other […]

View full entry

Tags: Ankylosing Spondylitis (AS), ask the expert, back pain, News Tips and Features Arthritis, Psoriatic Arthritis, rheumatoid arthritis


FDA Extends Simponi Approval to Psoriatic Arthritis and Ankylosing Spondylitis

October 26, 2017

FDA Extends Simponi Approval to Psoriatic Arthritis and Ankylosing Spondylitis

By cancerconnect cancerconnect

The US Food and Drug Administration recently approved Simponi (golimumab) for the treatment of adult patients with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS), which is administered as a 30-minute infusion. Simponi was originally approved in 2013 for the treatment of moderate-to-severe active rheumatoid arthritis.  Simponi® is one of five marketed TNF inhibitors […]

View full entry

Tags: Ankylosing Spondylitis, Ankylosing Spondylitis (AS), AS, golimumab, News Tips and Features, PsA, Psoriatic Arthritis, Simponi


Cosentyx Highly Effective for Treatment of Scalp Psoriasis

September 25, 2017

Cosentyx Highly Effective for Treatment of Scalp Psoriasis

By cancerconnect cancerconnect

Psoriasis is a chronic skin condition caused by an overactive immune system affecting 1-3% of people in the United States. Symptoms include flaking, inflammation, and thick, white, silvery, or red patches of the skin and scalp.  Psoriasis can also cause discoloration and pitting of finger and toenails as well as inflammation of the joints and […]

View full entry

Tags: Cosentyx, interleukin 17A, News Tips and Features, plaque psoriasis, Psoriatic Arthritis, secukinumab


Obesity- More Than a Weight Problem for Ankylosing Spondylitis (AS) and Other Rheumatic Conditions

July 31, 2017

Obesity- More Than a Weight Problem for Ankylosing Spondylitis (AS) and Other Rheumatic Conditions

By cancerconnect cancerconnect

Obesity is known to have detrimental effects on the musculoskeletal system because of the added strain on joint structures.  Another detrimental effect may be the blunting of a therapeutic response to a therapy. It has previously been reported that decreasing weight in psoriatic arthritis results in an improved responses to treatment with tumor necrosis factor […]

View full entry

Tags: Ankylosing Spondylitis, antibody therapy, axial spondyloarthritis, axSpA, Obesity, Psoriatic Arthritis, rheumatoid arthritis, TNFi, tumor necrosis factor


Xeljanz Effective in Ulcerative Colitis

May 17, 2017

Xeljanz Effective in Ulcerative Colitis

By cancerconnect cancerconnect

Xeljanz (tofacitinib) is currently approved by the U. S. Food and Drug Administration (FDA), for use in the treatment of rheumatoid arthritis.  Xeljanz is also being studied in numerous other inflammatory conditions including ankylosing spondylitis, psoriatic arthritis and ulcerative colitis (UC), a form of inflammatory bowel disease. UC is an inflammatory bowel disorder (IBD) as […]

View full entry

Tags: Ankylosing Spondylitis, inflammatory bowel disease., News Tips and Features, Psoriatic Arthritis, rheumatoid arthritis, ulcerative colitis, Xeljanz tofacitinib


How To Enjoy The Holidays Despite Chronic Pain

December 20, 2016

How To Enjoy The Holidays Despite Chronic Pain

By cancerconnect cancerconnect

By Tom Macek, M.D. The holidays are a time when everyone is encouraged to be of good cheer. But this joyous time of year is a lot less merry for those suffering from chronic bad backs, migraines, arthritis and other pain-inducing ailments. “Any kind of pain can seriously affect your quality of life,” says Dr. […]

View full entry

Tags: Ankylosing Spondylitis, Axial Spondyloarthropathy (axSpA), back strain, News Tips and Features, osteoarthritis, Psoriatic Arthritis, rheumatoid arthritis, Spondylolysis/Spondylolisthesis


Cosentyx® Improves Pain and Function in Patients with Psoriatic Arthritis

September 22, 2016

Cosentyx® Improves Pain and Function in Patients with Psoriatic Arthritis

By cancerconnect cancerconnect

By David Borenstein MD, Executive Editor, theSpineCommunity.com In January of 2016, the Food and Drug Administration approved Cosentyx® (secukinumab) for the treatment of psoriatic arthritis (PsA) and ankylosing spondylitis. Psoriatic spondylitis, an inflammatory spine disease, is a component of PsA responsive to Cosentyx therapy. The availability of Cosentyx allows another option for PsA patients with spine […]

View full entry

Tags: News Tips and Features, PsA, Psoriatic Arthritis


More News →

CONDITIONS OF THE GI TRACT